1-hydroxy-3-(3-methylbut-2-enyloxy)xanthone

ID: ALA228785

Chembl Id: CHEMBL228785

PubChem CID: 44424278

Max Phase: Preclinical

Molecular Formula: C18H16O4

Molecular Weight: 296.32

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)=CCOc1cc(O)c2c(=O)c3ccccc3oc2c1

Standard InChI:  InChI=1S/C18H16O4/c1-11(2)7-8-21-12-9-14(19)17-16(10-12)22-15-6-4-3-5-13(15)18(17)20/h3-7,9-10,19H,8H2,1-2H3

Standard InChI Key:  IZBWCGBOOSCKRX-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-268 (49410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-62 (47335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGAM Tclin Alpha glucosidase (860 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 296.32Molecular Weight (Monoisotopic): 296.1049AlogP: 4.00#Rotatable Bonds: 3
Polar Surface Area: 59.67Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.33CX Basic pKa: CX LogP: 4.51CX LogD: 4.46
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.59Np Likeness Score: 1.19

References

1. Castanheiro RA, Pinto MM, Silva AM, Cravo SM, Gales L, Damas AM, Nazareth N, Nascimento MS, Eaton G..  (2007)  Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.,  15  (18): [PMID:17614292] [10.1016/j.bmc.2007.06.037]
2. Santos CMM, Freitas M, Fernandes E..  (2018)  A comprehensive review on xanthone derivatives as α-glucosidase inhibitors.,  157  [PMID:30282319] [10.1016/j.ejmech.2018.07.073]

Source